Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Endoscopic therapy+ PSE
PROCEDURE
2 trials
Sponsors
Yanjing Gao
, Qilu Hospital of Shandong University
Conditions
Esophageal and Gastric Varices
Hepatic Cirrhosis
Hypersplenism
Liver Cirrhosis
Portal Hypertension
Unknown Phase
The Treatment of Hepatocirrhosis and Portal Hypertension
Completed
NCT02778425
Yanjing Gao
Hepatic Cirrhosis, Portal Hypertension
Start: 2016-02-29
End: 2020-01-31
Updated: 2025-02-14
A Randomized Controlled Study on the Treatment of Cirrhosis Combined With Hypersplenism
NCT05055713
Qilu Hospital of Shandong University
Esophageal and Gastric Varices, Hypersplenism, Liver Cirrhosis
Start: 2020-09-25
End: 2022-12-31
Target: 368
Updated: 2022-03-02
Related Papers
Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multicenter randomized controlled trial.
2023-07-24
1 citations
Partial splenic embolization combined with endoscopic therapies and NSBB decreases the variceal rebleeding rate in cirrhosis patients with hypersplenism: a multicenter randomized controlled trial.
2021-02-27
18 citations